| Literature DB >> 21416656 |
Robert Reid, Nicholas Leyland, Wendy Wolfman, Catherine Allaire, Alaa Awadalla, Carolyn Best, Sheila Dunn, Madeleine Lemyre, Violaine Marcoux, Chantal Menard, Frank Potestio, David Rittenberg, Sukhbir Singh, Vyta Senikas.
Abstract
OBJECTIVE: To provide current and emerging evidence on oral contraceptives and the risk of venous thromboembolism. EVIDENCE: Articles published in English from 2005 were retrieved through searches of PubMed and Medline, using the following terms: venous thromboembolism, VTE, contraception, oral contraceptives, hormonal contraception. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Searches were updated on a regular basis and incorporated in the guideline to May 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. VALUES: The quality of evidence was rated using the criteria described by the Canadian Task Force on Preventive Health Care (Table).Entities:
Mesh：
Substances：
Year: 2011 PMID： 21416656 DOI： 10.1016/j.ijgo.2010.12.003
Source DB: PubMed Journal: Int J Gynaecol Obstet ISSN： 0020-7292 Impact factor: 3.561